{
  "0P0000XMRD.L": {
    "category": "Sector Equity Biotechnology",
    "currency": "GBp",
    "exchange": "LSE",
    "family": "AXA Investment Managers UK Ltd",
    "long_name": "AXA Framlington Biotech Fund GBP Z Acc",
    "manager_bio": "",
    "manager_name": "Linden  Thomson",
    "market": "gb_market",
    "short_name": "AXA Framlington Biotech Fund GB",
    "summary": "The aim of this Fund is to provide long-term capital growth. The Fund invests in shares of listed companies, principally in the biotechnology, genomic and medical research industry, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world, albeit the Fund tends to be biased towards the US as this is where the majority of biotechnology companies are based. The Manager selects shares based upon analysis of a companyâs financial status, quality of its management, expected profitability and prospects for growth.",
    "total_assets": null
  },
  "0P0001562A.F": {
    "category": "Sector Equity Biotechnology",
    "currency": "EUR",
    "exchange": "FRA",
    "family": "FinanciÃ¨re Arbevel",
    "long_name": "Pluvalca Health Opportunities A",
    "manager_bio": "",
    "manager_name": "SÃ©bastien  LalevÃ©e",
    "market": "dr_market",
    "short_name": "Pluvalca Inno Santé A",
    "summary": "PLUVALCA HEALTH OPPORTUNITIES a pour objectif de gestion la recherche dâune performance supÃ©rieure Ã  10% (nette de frais de gestion) en rythme annuel moyen sur la durÃ©e de placement recommandÃ©e au travers dâune sÃ©lection rigoureuse de valeurs tout en faisant bÃ©nÃ©ficier ses souscripteurs dâune expertise diffÃ©renciante sur le marchÃ© europÃ©en en matiÃ¨re de sÃ©lection de sociÃ©tÃ©s de biotechnologies innovantes dans le secteur de la santÃ©.",
    "total_assets": 33559612.53762245
  },
  "SELJLB.MI": {
    "category": "Sector Equity Biotechnology",
    "currency": "EUR",
    "exchange": "MIL",
    "family": "SELECTRA MANAGEMENT COMPANY S.A.",
    "long_name": "Selectra J. Lamarck Biotech Fund Class D",
    "manager_bio": "",
    "manager_name": "Not  Disclosed",
    "market": "it_market",
    "short_name": "SELECTRA J. LAMARCK BIOTECH CLA",
    "summary": "The main objective of this sub-fund is to profit from increasing share prices in the biotechnology sector. The focus is on mature top tier pharmaceutical biotech companies and companies with interesting pipeline of products in development in a single or numerous markets, like Nasdaq or NYSE. The followed investment policy will enable the Sub-Fund to increase overall return relative to the Nasdaq Biotech Index by active stock selection of companies, offering the most promising technology platform.",
    "total_assets": null
  }
}
